U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607600) titled 'Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked Hypophosphatemia' on May 19.
Brief Summary: The purpose of this study is to better understand how X-linked hypophosphatemia (XLH) affects the body and daily life. Phosphate levels are critical in managing XLH, we aim to study how these levels change in patients taking burosumab and how they relate to bone health, overall disease burden and XLH-related conditions.
Study Start Date: July 07
Study Type: OBSERVATIONAL
Condition:
X-linked Hypophosphatemia (XLH)
Intervention:
OTHER: No treatment given
No treatment given
Recruitment Status: NOT_YE...